Essential medicines selection

Medicines for treatment of the following cancers – review – EML and EMLc

20th Expert Committee on the Selection and Use of Essential Medicines

Drug information:

Section 8: Antineoplastic and immunosuppressives
8.2: Cytotoxic and adjuvant medicines

Formulation:

Application prepared by:
Union for International Cancer Control



Acute myelogenous leukemia or acute myeloid leukemia (AML)
Chronic lymphocytic leukemia (CLL)
Chronic myelogenous leukemia (CML)
Diffuse large B-cell lymphoma (DLBCL)
Early stage breast cancer
Early stage cervical cancer
Early stage colon cancer
Early stage rectal cancer
Epithelial ovarian cancer
Ewing sarcoma
Follicular lymphoma (FL)
Gastrointestinal stromal tumours (GIST)
Gestational trophoblastic neoplasms (GTN)
Granulocyte stimulating agents (G-CSF)
Head and neck cancer
Hodgkin lymphoma (HL) adult
Hodgkin lymphoma (HL) paediatric
Kaposi sarcoma (KS)
Metastatic breast cancer
Metastatic colorectal cancer
Metastatic prostate cancer
Nasopharyngeal carcinoma (NPC)
Non-small cell lung cancer (NSCLC)
Osteosarcoma
Ovarian germ cell tumours (OGCTs)
Paediatric cancers
Retinoblastoma
Rhabdomyosarcoma (RMS)
Testicular germ cell tumours

Public comments:

Share